GHK-Cu Copper Peptide: What the Research Shows

Research Use Only: The information below summarises published scientific literature for laboratory and research audiences. It is not medical advice, and the compound discussed is not approved for human or veterinary use.

What is GHK-Cu?

GHK-Cu is a copper-binding tripeptide made of the amino acids glycine, histidine and lysine (Gly-His-Lys) complexed with a copper(II) ion. The GHK sequence was first isolated from human plasma in 1973 by Loren Pickart, and it has been the subject of continuous research ever since. Plasma levels of GHK are highest in young adults and decline with age, which is one reason the peptide has attracted so much research interest.

Among research peptides, GHK-Cu is one of the most studied copper peptides, with a large body of literature covering gene expression, extracellular-matrix biology and cell-culture models.

Where GHK-Cu sits in the research literature

The GHK-Cu evidence base is dominated by in vitro (cell) and in vivo (animal) studies, along with gene-expression analyses. A widely cited 2018 review reported that GHK-Cu can influence the expression of a large fraction of human genes in laboratory models.

Reported areas of preclinical interest

• Extracellular-matrix models: studies describe stimulation of fibroblast proliferation and upregulation of genes linked to collagen, elastin and proteoglycans in cell culture.
• Copper transport: research examines GHK as a carrier that delivers copper ions relevant to numerous enzymatic pathways.
• Antioxidant and signalling pathways: laboratory work explores gene-regulatory and redox-related effects.

GHK-Cu chemistry at a glance

GHK-Cu is a small tripeptide (Gly-His-Lys) that chelates a copper(II) ion through its histidine and terminal amino groups, giving solutions a characteristic blue tint. It is typically supplied as a lyophilised powder for laboratory reconstitution. These are physicochemical properties relevant to handling and analysis, not indications of any human use.

Why the “research use only” label matters

GHK-Cu supplied as a research chemical has not been approved by the FDA, EMA or any comparable authority as a medicinal product, and cosmetic use of copper peptides is a separate regulatory category with its own rules. Research-grade material is intended strictly for laboratory and scientific work and is not for human or veterinary consumption.

GHK-Cu in blended research compounds

In the research market, GHK-Cu is often studied alongside other peptides investigated for matrix and tissue-support pathways. Our GHK-Cu research peptide, our GLOW research blend (GHK-Cu, TB-500, BPC-157) and our GHK-Cu / Minoxidil research formulation are examples of products intended purely for laboratory research.

Handling and storage considerations for researchers

Copper peptides such as GHK-Cu are generally supplied lyophilised and kept cool, dry and protected from light, with reconstituted solution refrigerated and used within the stability window indicated for each batch. Copper complexes can be sensitive to pH and oxidation, so follow the documentation supplied with the product and your institution’s handling protocols.

Frequently asked questions

What does GHK-Cu stand for?

GHK refers to the tripeptide glycine-histidine-lysine, and Cu is the chemical symbol for copper. GHK-Cu is the copper-bound form of the peptide.

Is GHK-Cu approved for human use?

Research-grade GHK-Cu is a laboratory chemical and is not approved as a medicinal product. It is not intended for human or veterinary use.

What studies exist on GHK-Cu?

The literature is largely made up of cell-culture, animal and gene-expression studies. Findings from these models should not be extrapolated to people.

How should GHK-Cu be stored in a lab?

Keep lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution. Follow the stability guidance provided with each batch.

Key takeaways

GHK-Cu is a naturally occurring copper tripeptide with a deep preclinical literature focused on extracellular-matrix and gene-expression pathways. It remains a research material: not approved as a medicine, and intended only for laboratory work. Researchers exploring copper-peptide formulations can review our GHK-Cu and GLOW blend research products.

References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. PMC6073405.
2. Skin permeation of GHK-Cu tripeptide encapsulated in liposomes. PMC11721469.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.